SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of December 15, 2025, SNN stock price declined to $32.38 with 26,073 million shares trading.

SNN has a beta of 0.74, meaning it tends to be less sensitive to market movements. SNN has a correlation of 0.20 to the broad based SPY ETF.

SNN has a market cap of $13.74 billion. This is considered a Large Cap stock.

In the last 3 years, SNN traded as high as $38.79 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): AVDE, BINV, DFIC, APIE, KOMP.

SNN has outperformed the market in the last year with a return of +29.8%, while the SPY ETF gained +14.4%. However, in the most recent history, SNN shares have underperformed the stock market with its stock returning -13.5% in the last 3 month period and -2.7% for the last 2 week period, while SPY has returned +4.4% and +0.1%, respectively.

SNN support price is $32.23 and resistance is $33.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN shares will trade within this expected range on the day.